You are using an outdated browser. Please
upgrade your browser to improve your experience.
The EUROSTAD study OBS14620 eDiary App has been developed for the Prospective Observational Study to characterise the medication history, demographic characteristics and previous treatment of Atopic Dermatitis (AD) in patients treated with systemic immunosuppressive therapy for AD
EUROSTAD
by Exco InTouch
What is it about?
The EUROSTAD study OBS14620 eDiary App has been developed for the Prospective Observational Study to characterise the medication history, demographic characteristics and previous treatment of Atopic Dermatitis (AD) in patients treated with systemic immunosuppressive therapy for AD.
App Store Description
The EUROSTAD study OBS14620 eDiary App has been developed for the Prospective Observational Study to characterise the medication history, demographic characteristics and previous treatment of Atopic Dermatitis (AD) in patients treated with systemic immunosuppressive therapy for AD.
The App will collect eDiary information for subject registered into this study.
*Note: this App requires an activation code and can only be accessed by subjects who are participating in the OBS14620 trial.
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
